SLS Katherine Bach Kalin buys $36K worth of shares
May 23, 2025, 4:36 AM
0.00%
What does SLS do
SELLAS Life Sciences Group, a clinical stage biopharmaceutical company based in New York, develops immunotherapeutics for cancer, including galinpepimut-S and SLS009. The company went public in 2008 and employs 16 staff.
Katherine Bach Kalin bought 20,000 shares of SLS on 22 May at $1.80 per share, worth a total of $36K. They now own 41,000 SLS shares, or a 95% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
